CD274 and neoplasm: This is probably related to the immune microenvironment of the tumor, where PD-L1 is also expressed on immune cells (on helper T cells—CD4+, killer T cells—CD8+, regulatory T lymphocytes—Treg, B lymphocytes, killer cells—CD56+ and monocytes -macrophage cells) and contributes to antitumor immunity.